MANILA, Oct 17 (Mabuhay) — Results of the clinical trials on the efficacy of virgin coconut oil (VCO) against the coronavirus disease 2019 are expected to be released by the second week of November, the Department of Science and Technology said Saturday.
“After today ay ia-analyze na ‘yung data. Siguro second week of November alam na natin kung ano ang finding,” DOST Secretary Fortunato dela Peña said in a Dobol B sa News TV interview.
Early on, the DOST aimed to have 45 participating patients who will have virgin coconut oil mixed into their meals, and another 45 without VCO in order for researchers to compare results.
“Ang hope natin ay yung mga napabilis ang paggaling ay ‘yun nga ang binigyan ng VCO,” Dela Peña said.
“At saka wala naman siyang harmful effects,” he added.
Dela Peña also reported that admission of severe COVID-19 cases at the Philippine General Hospital had declined amid the ongoing trials of Lagundi as a supplemental treatment.
“‘Yung mga severe cases sa PGH parang dumadalang ang admission. Kahapon isa lang ‘yung kanilang kinausap, hindi pa nag-volunteer,” he said. “Sabi sa akin, madalang ang dating ng pasyente.”
On June 3, the PGH ethics board of the University of the Philippines-Manila approved the inclusion of some COVID-19 patients in clinical trials for VCO.
On October 9, the DOST announced that clinical trials for lagundi as a medicine to prevent severe COVID-19 cases has started. (MNS)